Article Details

HanAll's Licensed Partner in China Enters Sublicense Agreement with CSPC to Further ...

Retrieved on: 2022-10-11 11:34:16

Tags for this article:

Click the tags to see associated articles and topics

HanAll's Licensed Partner in China Enters Sublicense Agreement with CSPC to Further .... View article details on hiswai:

Excerpt

SEOUL, South Korea, Oct. 11, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS), a global biopharmaceutical company developing innovative ...

Article found on: en.prnasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up